Dr. Zibelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-2500Fax+1 215-728-3639- Is this information wrong?
Education & Training
- Temple University HospitalFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2007 - 2011
- Lewis Katz School of Medicine at Temple UniversityClass of 2007
Certifications & Licensure
- PA State Medical License 2012 - 2024
- IL State Medical License 2007 - 2014
- WI State Medical License 2011 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors Start of enrollment: 2015 Dec 11
- Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma Start of enrollment: 2017 Jun 12
- Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma Start of enrollment: 2017 Nov 27
- Join now to see all
Publications & Presentations
PubMed
- Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S...Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo, Andrea Harzstark, Channing J Paller, Saby George, Matthew R Zibelman, Heather ...> ;European Urology Oncology. 2024 Mar 23
- NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Hilary Bagshaw, Michael Baine, Kathryn Beckermann, Maria I Carlo, Toni K Choueiri, Brian A Costello, Ithaar ...> ;Journal of the National Comprehensive Cancer Network. 2024 Feb 1
- 2 citationsA phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.Matthew Zibelman, Alexander W MacFarlane 4th, Kimberly Costello, Thomas McGowan, John O'Neill, Rutika Kokate, Hossein Borghaei, Crystal S Denlinger, Efrat Dotan, Danie...> ;Nature Communications. 2023 Jul 27
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Fox Chase Cancer CenterPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: